• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

谷胱甘肽纳米颗粒、辅酶Q10和鱼油预防新生大鼠氧诱导视网膜病变的比较

Comparison of Glutathione Nanoparticles, CoEnzyme Q10, and Fish Oil for Prevention of Oxygen-Induced Retinopathy in Neonatal Rats.

作者信息

Bashir Sidra, Cai Charles L, Marcelino Matthew, Aranda Jacob V, Beharry Kay D

机构信息

Department of Pediatrics, Division of Neonatal-Perinatal Medicine, State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA.

Medical School, State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA.

出版信息

Pharmaceuticals (Basel). 2024 Mar 17;17(3):381. doi: 10.3390/ph17030381.

DOI:10.3390/ph17030381
PMID:38543167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10975314/
Abstract

Notch ligands and receptors are important for cell specification and angiogenesis, but their role in oxygen-induced retinopathy (OIR) is not well studied. Delta-like ligand (DLL)-4/Notch inhibits angiogenesis, while Jagged-1/Notch promotes angiogenesis. We tested the hypothesis that early supplementation with antioxidants and/or fish oil curtails severe OIR by inducing DLL-4/Notch and reducing Jagged-1/Notch. Newborn rats were exposed to brief intermittent hypoxia (IH) during hyperoxia, during which they received daily oral supplements of (1) fish oil, (2) coenzyme Q10 (CoQ10) in olive oil (OO), (3) glutathione nanoparticles (nGSH), (4) fish oil + CoQ10, or (5) OO (controls) from birth (P0) to P14. At P14, the pups were placed in room air (RA) until P21, with no further treatment. Oxidative stress, apoptosis, ocular histopathology, and Notch signaling were assessed. Neonatal IH resulted in severe retinal damage consistent with retinopathy of prematurity (ROP). Retinal damage was associated with induced oxidative stress and Jagged-1/Notch signaling, as well as reduced DLL-4/Notch signaling. All treatments reversed these outcomes, but nGSH produced the most beneficial outcomes. Severe OIR promoted the induction of Jagged-1/Notch and curtailed DLL-4/Notch, which was an effect that could be reversed with nGSH supplementation. These findings may indicate a potential alternate pathway for ROP treatment and/or prevention.

摘要

Notch配体和受体对细胞分化及血管生成很重要,但其在氧诱导性视网膜病变(OIR)中的作用尚未得到充分研究。Delta样配体(DLL)-4/Notch抑制血管生成,而Jagged-1/Notch促进血管生成。我们验证了以下假设:早期补充抗氧化剂和/或鱼油可通过诱导DLL-4/Notch并减少Jagged-1/Notch来减轻严重的OIR。新生大鼠在高氧环境下暴露于短暂间歇性缺氧(IH),在此期间,从出生(P0)到P14,它们每天接受以下口服补充剂:(1)鱼油,(2)橄榄油(OO)中的辅酶Q10(CoQ10),(3)谷胱甘肽纳米颗粒(nGSH),(4)鱼油 + CoQ10,或(5)OO(对照组)。在P14时,将幼崽置于室内空气(RA)中直至P21,不再进行进一步治疗。评估氧化应激、细胞凋亡、眼部组织病理学和Notch信号传导。新生儿IH导致与早产儿视网膜病变(ROP)一致的严重视网膜损伤。视网膜损伤与诱导的氧化应激和Jagged-1/Notch信号传导以及减少的DLL-4/Notch信号传导相关。所有治疗均逆转了这些结果,但nGSH产生了最有益的结果。严重的OIR促进了Jagged-1/Notch的诱导并减少了DLL-4/Notch,而补充nGSH可逆转这种效应。这些发现可能表明ROP治疗和/或预防的潜在替代途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/9d83a29f02fb/pharmaceuticals-17-00381-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/909e29ebe894/pharmaceuticals-17-00381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/3234c78570c3/pharmaceuticals-17-00381-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/0fab56a58256/pharmaceuticals-17-00381-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/0933656e5d3e/pharmaceuticals-17-00381-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/e486d451835b/pharmaceuticals-17-00381-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/22000f48368f/pharmaceuticals-17-00381-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/42310484d8f1/pharmaceuticals-17-00381-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/cc35015ab0f3/pharmaceuticals-17-00381-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/28d38fe43652/pharmaceuticals-17-00381-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/da5ff0c4b401/pharmaceuticals-17-00381-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/3606b26fe62b/pharmaceuticals-17-00381-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/dd10dd448195/pharmaceuticals-17-00381-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/6fd1a10c9fae/pharmaceuticals-17-00381-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/9d83a29f02fb/pharmaceuticals-17-00381-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/909e29ebe894/pharmaceuticals-17-00381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/3234c78570c3/pharmaceuticals-17-00381-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/0fab56a58256/pharmaceuticals-17-00381-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/0933656e5d3e/pharmaceuticals-17-00381-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/e486d451835b/pharmaceuticals-17-00381-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/22000f48368f/pharmaceuticals-17-00381-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/42310484d8f1/pharmaceuticals-17-00381-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/cc35015ab0f3/pharmaceuticals-17-00381-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/28d38fe43652/pharmaceuticals-17-00381-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/da5ff0c4b401/pharmaceuticals-17-00381-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/3606b26fe62b/pharmaceuticals-17-00381-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/dd10dd448195/pharmaceuticals-17-00381-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/6fd1a10c9fae/pharmaceuticals-17-00381-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e09/10975314/9d83a29f02fb/pharmaceuticals-17-00381-g014.jpg

相似文献

1
Comparison of Glutathione Nanoparticles, CoEnzyme Q10, and Fish Oil for Prevention of Oxygen-Induced Retinopathy in Neonatal Rats.谷胱甘肽纳米颗粒、辅酶Q10和鱼油预防新生大鼠氧诱导视网膜病变的比较
Pharmaceuticals (Basel). 2024 Mar 17;17(3):381. doi: 10.3390/ph17030381.
2
Biomarkers of lung alveolarization and microvascular maturation in response to intermittent hypoxia and/or early antioxidant/fish oil supplementation in neonatal rats.新生儿大鼠间歇性低氧和/或早期抗氧化/鱼油补充对肺肺泡化和微血管成熟的生物标志物反应。
Pediatr Pulmonol. 2023 Aug;58(8):2352-2363. doi: 10.1002/ppul.26495. Epub 2023 Jun 2.
3
Biomarkers of growth and carbohydrate metabolism in neonatal rats supplemented with fish oil and/or antioxidants during intermittent hypoxia.在间歇性低氧期间补充鱼油和/或抗氧化剂的新生大鼠生长和碳水化合物代谢的生物标志物。
Growth Horm IGF Res. 2023 Feb;68:101513. doi: 10.1016/j.ghir.2022.101513. Epub 2022 Nov 5.
4
Coenzyme Q10 and Fish Oil Supplementation for Reducing Retinal Oxidative Stress in a Rat Model.辅酶Q10和鱼油补充剂对降低大鼠模型视网膜氧化应激的作用
Vision (Basel). 2023 Mar 11;7(1):20. doi: 10.3390/vision7010020.
5
Neonatal intermittent hypoxia, fish oil, and/or antioxidant supplementation on gut microbiota in neonatal rats.新生儿间歇性缺氧、鱼油和/或抗氧化剂补充对新生大鼠肠道微生物群的影响。
Pediatr Res. 2022 Jul;92(1):109-117. doi: 10.1038/s41390-021-01707-z. Epub 2021 Aug 28.
6
Comparative Effects of Coenzyme Q10 or -3 Polyunsaturated Fatty Acid Supplementation on Retinal Angiogenesis in a Rat Model of Oxygen-Induced Retinopathy.辅酶Q10或-3多不饱和脂肪酸补充剂对氧诱导性视网膜病变大鼠模型视网膜血管生成的比较作用
Antioxidants (Basel). 2018 Nov 9;7(11):160. doi: 10.3390/antiox7110160.
7
Combination Antioxidant/NSAID Therapies and Oral/Topical Ocular Delivery Modes for Prevention of Oxygen-Induced Retinopathy in a Rat Model.抗氧化剂/非甾体抗炎药联合治疗及口服/局部眼内递药模式防治氧诱导视网膜病变的大鼠模型研究。
Nutrients. 2020 Jul 3;12(7):1980. doi: 10.3390/nu12071980.
8
Effects of omega 3 polyunsaturated fatty acids, antioxidants, and/or non-steroidal inflammatory drugs in the brain of neonatal rats exposed to intermittent hypoxia.ω-3多不饱和脂肪酸、抗氧化剂和/或非甾体类抗炎药对暴露于间歇性低氧环境的新生大鼠大脑的影响。
Int J Dev Neurosci. 2021 Aug;81(5):448-460. doi: 10.1002/jdn.10120. Epub 2021 May 25.
9
Antioxidants and/or fish oil reduce intermittent hypoxia-induced inflammation in the neonatal rat terminal ileum.抗氧化剂和/或鱼油可减轻新生儿大鼠回肠末端间歇性缺氧引起的炎症。
Prostaglandins Other Lipid Mediat. 2021 Aug;155:106565. doi: 10.1016/j.prostaglandins.2021.106565. Epub 2021 May 26.
10
Comparison of coenzyme Q10 or fish oil for prevention of intermittent hypoxia-induced oxidative injury in neonatal rat lungs.比较辅酶 Q10 或鱼油对预防新生大鼠间歇性低氧诱导肺氧化损伤的作用。
Respir Res. 2021 Jul 5;22(1):196. doi: 10.1186/s12931-021-01786-w.

引用本文的文献

1
Baicalein ameliorates cognitive decline induced by chronic cerebral hypoperfusion through the SIRT1-mediated Notch1 pathway to improve angiogenesis and suppress neuroinflammation.黄芩苷通过SIRT1介导的Notch1信号通路改善慢性脑灌注不足诱导的认知功能衰退,以促进血管生成并抑制神经炎症。
Front Aging Neurosci. 2025 Apr 11;17:1521353. doi: 10.3389/fnagi.2025.1521353. eCollection 2025.

本文引用的文献

1
Coenzyme Q10 and Fish Oil Supplementation for Reducing Retinal Oxidative Stress in a Rat Model.辅酶Q10和鱼油补充剂对降低大鼠模型视网膜氧化应激的作用
Vision (Basel). 2023 Mar 11;7(1):20. doi: 10.3390/vision7010020.
2
Association of fish oil containing lipid emulsions with retinopathy of prematurity: a retrospective observational study.含鱼油的脂肪乳剂与早产儿视网膜病变的关联:一项回顾性观察研究。
BMC Pediatr. 2022 Mar 2;22(1):113. doi: 10.1186/s12887-022-03174-9.
3
Ophthalmic complications in retinopathy of prematurity in the first decade of life in Korea using the national health insurance database.
韩国使用国家健康保险数据库研究生命最初十年中早产儿视网膜病变的眼部并发症。
Sci Rep. 2022 Jan 18;12(1):911. doi: 10.1038/s41598-021-04616-7.
4
A novel peptide inhibitor of Dll4-Notch1 signalling and its pro-angiogenic functions.一种新型 DLL4-Notch1 信号通路肽抑制剂及其促血管生成功能。
Br J Pharmacol. 2022 Apr;179(8):1716-1731. doi: 10.1111/bph.15743. Epub 2022 Jan 11.
5
Assessment of serum catalase, reduced glutathione, and superoxide dismutase activities and malondialdehyde levels in keratoconus patients.评估圆锥角膜患者血清过氧化氢酶、还原型谷胱甘肽、超氧化物歧化酶活性和丙二醛水平。
Eye (Lond). 2022 Oct;36(10):2062-2066. doi: 10.1038/s41433-021-01753-1. Epub 2021 Aug 30.
6
Combination Antioxidant/NSAID Therapies and Oral/Topical Ocular Delivery Modes for Prevention of Oxygen-Induced Retinopathy in a Rat Model.抗氧化剂/非甾体抗炎药联合治疗及口服/局部眼内递药模式防治氧诱导视网膜病变的大鼠模型研究。
Nutrients. 2020 Jul 3;12(7):1980. doi: 10.3390/nu12071980.
7
Current evidence and outcomes for retinopathy of prematurity prevention: insight into novel maternal and placental contributions.早产儿视网膜病变预防的当前证据与成果:洞察母体和胎盘的新作用
Explor Med. 2020;1:4-26. doi: 10.37349/emed.2020.00002. Epub 2020 Feb 29.
8
Effects of fish oil-containing lipid emulsions on retinopathy of prematurity in very low birth weight infants.富含鱼油的脂肪乳剂对极低出生体重儿早产儿视网膜病变的影响。
Pediatr Neonatol. 2020 Apr;61(2):224-230. doi: 10.1016/j.pedneo.2019.11.010. Epub 2019 Nov 30.
9
Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment.早产儿视网膜病变的退行性变与玻璃体内注射贝伐单抗治疗后的神经发育结局。
PLoS One. 2019 Oct 16;14(10):e0223972. doi: 10.1371/journal.pone.0223972. eCollection 2019.
10
Short-term retinal detachment risk after treatment of type 1 retinopathy of prematurity with laser photocoagulation versus intravitreal bevacizumab.激光光凝与玻璃体内注射贝伐单抗治疗 1 型早产儿视网膜病变后短期视网膜脱离风险。
J AAPOS. 2019 Oct;23(5):260.e1-260.e4. doi: 10.1016/j.jaapos.2019.05.013. Epub 2019 Sep 9.